vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and UNIVERSAL DISPLAY CORP \PA\ (OLED). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $142.2M, roughly 1.7× UNIVERSAL DISPLAY CORP \PA\). UNIVERSAL DISPLAY CORP \PA\ runs the higher net margin — 25.2% vs -35.0%, a 60.3% gap on every dollar of revenue. On growth, UNIVERSAL DISPLAY CORP \PA\ posted the faster year-over-year revenue change (-14.5% vs -23.6%). Over the past eight quarters, UNIVERSAL DISPLAY CORP \PA\'s revenue compounded faster (-5.3% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Universal Display Corporation is a developer and manufacturer of organic light emitting diode (OLED) technologies and materials, and it is a provider of services to the display and lighting industries.
CCRN vs OLED — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $142.2M |
| Net Profit | $-82.9M | $35.9M |
| Gross Margin | — | 74.6% |
| Operating Margin | -30.2% | 30.1% |
| Net Margin | -35.0% | 25.2% |
| Revenue YoY | -23.6% | -14.5% |
| Net Profit YoY | -2109.7% | -44.3% |
| EPS (diluted) | $-2.56 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $142.2M | ||
| Q4 25 | $236.8M | $172.9M | ||
| Q3 25 | $250.1M | $139.6M | ||
| Q2 25 | $274.1M | $171.8M | ||
| Q1 25 | $293.4M | $166.3M | ||
| Q4 24 | $309.9M | $162.3M | ||
| Q3 24 | $315.1M | $161.6M | ||
| Q2 24 | $339.8M | $158.5M |
| Q1 26 | — | $35.9M | ||
| Q4 25 | $-82.9M | $66.3M | ||
| Q3 25 | $-4.8M | $44.0M | ||
| Q2 25 | $-6.7M | $67.3M | ||
| Q1 25 | $-490.0K | $64.4M | ||
| Q4 24 | $-3.8M | $46.0M | ||
| Q3 24 | $2.6M | $66.9M | ||
| Q2 24 | $-16.1M | $52.3M |
| Q1 26 | — | 74.6% | ||
| Q4 25 | — | 76.1% | ||
| Q3 25 | 20.4% | 74.6% | ||
| Q2 25 | 20.4% | 77.2% | ||
| Q1 25 | 20.0% | 77.1% | ||
| Q4 24 | — | 77.0% | ||
| Q3 24 | 20.4% | 77.8% | ||
| Q2 24 | 20.8% | 75.8% |
| Q1 26 | — | 30.1% | ||
| Q4 25 | -30.2% | 38.9% | ||
| Q3 25 | -2.4% | 30.9% | ||
| Q2 25 | -2.1% | 39.9% | ||
| Q1 25 | -0.3% | 41.9% | ||
| Q4 24 | -1.1% | 32.3% | ||
| Q3 24 | 0.9% | 41.5% | ||
| Q2 24 | -5.7% | 35.6% |
| Q1 26 | — | 25.2% | ||
| Q4 25 | -35.0% | 38.4% | ||
| Q3 25 | -1.9% | 31.5% | ||
| Q2 25 | -2.4% | 39.2% | ||
| Q1 25 | -0.2% | 38.8% | ||
| Q4 24 | -1.2% | 28.4% | ||
| Q3 24 | 0.8% | 41.4% | ||
| Q2 24 | -4.7% | 33.0% |
| Q1 26 | — | $0.76 | ||
| Q4 25 | $-2.56 | $1.40 | ||
| Q3 25 | $-0.15 | $0.92 | ||
| Q2 25 | $-0.20 | $1.41 | ||
| Q1 25 | $-0.02 | $1.35 | ||
| Q4 24 | $-0.13 | $0.96 | ||
| Q3 24 | $0.08 | $1.40 | ||
| Q2 24 | $-0.47 | $1.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $516.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | — |
| Total Assets | $449.0M | $1.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $516.4M | ||
| Q4 25 | $108.7M | $602.4M | ||
| Q3 25 | $99.1M | $603.0M | ||
| Q2 25 | $81.2M | $525.2M | ||
| Q1 25 | $80.7M | $571.3M | ||
| Q4 24 | $81.6M | $492.7M | ||
| Q3 24 | $64.0M | $551.6M | ||
| Q2 24 | $69.6M | $530.5M |
| Q1 26 | — | — | ||
| Q4 25 | $322.8M | $1.8B | ||
| Q3 25 | $408.1M | $1.7B | ||
| Q2 25 | $412.2M | $1.7B | ||
| Q1 25 | $418.2M | $1.7B | ||
| Q4 24 | $419.0M | $1.6B | ||
| Q3 24 | $424.7M | $1.6B | ||
| Q2 24 | $433.3M | $1.5B |
| Q1 26 | — | $1.9B | ||
| Q4 25 | $449.0M | $2.0B | ||
| Q3 25 | $538.2M | $1.9B | ||
| Q2 25 | $553.8M | $1.9B | ||
| Q1 25 | $576.2M | $1.9B | ||
| Q4 24 | $589.3M | $1.8B | ||
| Q3 24 | $597.4M | $1.8B | ||
| Q2 24 | $602.9M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $108.9M |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | 3.03× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $108.9M | ||
| Q4 25 | $18.2M | $31.1M | ||
| Q3 25 | $20.1M | $97.2M | ||
| Q2 25 | $4.2M | $51.9M | ||
| Q1 25 | $5.7M | $30.6M | ||
| Q4 24 | $24.2M | $34.7M | ||
| Q3 24 | $7.5M | $79.9M | ||
| Q2 24 | $82.4M | $67.0M |
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | $15.1M | ||
| Q3 25 | $17.9M | $84.3M | ||
| Q2 25 | $2.3M | $37.5M | ||
| Q1 25 | $3.8M | $17.5M | ||
| Q4 24 | $21.7M | $22.0M | ||
| Q3 24 | $6.3M | $66.2M | ||
| Q2 24 | $79.6M | $57.9M |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 8.7% | ||
| Q3 25 | 7.2% | 60.4% | ||
| Q2 25 | 0.8% | 21.8% | ||
| Q1 25 | 1.3% | 10.5% | ||
| Q4 24 | 7.0% | 13.6% | ||
| Q3 24 | 2.0% | 41.0% | ||
| Q2 24 | 23.4% | 36.5% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 9.3% | ||
| Q3 25 | 0.9% | 9.2% | ||
| Q2 25 | 0.7% | 8.4% | ||
| Q1 25 | 0.6% | 7.9% | ||
| Q4 24 | 0.8% | 7.8% | ||
| Q3 24 | 0.4% | 8.4% | ||
| Q2 24 | 0.8% | 5.8% |
| Q1 26 | — | 3.03× | ||
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | 2.21× | ||
| Q2 25 | — | 0.77× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 0.75× | ||
| Q3 24 | 2.92× | 1.19× | ||
| Q2 24 | — | 1.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
OLED
| Material sales | $83.7M | 59% |
| Royalty and license fees | $54.2M | 38% |
| Contract research services | $4.3M | 3% |
